Kisspeptin Inhibits Colorectal Cancer Cell Invasiveness by Activating PKR and PP2A

Jeong Nam Kim1, Tae Hun Kim2, Ji-Hye Yoon2

  • 1Department of Microbiology, College of Natural Sciences, Pusan National University, Pusan, Republic of Korea.

Anticancer Research
|October 3, 2018
PubMed
Abstract

Insights

Kisspeptin inhibits colorectal cancer metastasis by activating protein kinase R (PKR) and protein phosphatase 2A (PP2A). This pathway suppresses cancer cell invasion without affecting proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide.
  • Metastasis is a complex process involving cancer cell invasion and migration.
  • Understanding the molecular mechanisms regulating CRC metastasis is crucial for developing effective therapies.

Purpose of the Study:

  • To elucidate the mechanism by which kisspeptin inhibits colorectal cancer metastasis.
  • To investigate the role of kisspeptin receptor (KISS1R) in this process.
  • To determine the involvement of protein kinase R (PKR) and protein phosphatase 2A (PP2A) in kisspeptin's anti-metastatic effects.

Main Methods:

  • Colorectal cancer cells were treated with kisspeptin.
  • Assays were performed to evaluate cell viability, migration, invasion, and anchorage-independent growth.
  • Kisspeptin receptor (KISS1R) requirement was assessed using siRNA gene silencing.
  • Western blot analysis and invasion assays were conducted.
  • The regulation of PKR and PP2A by kisspeptin was examined using specific inhibitors.

Main Results:

  • Kisspeptin significantly inhibited colorectal cancer cell invasiveness.
  • Kisspeptin's effect was dependent on KISS1R activation.
  • Kisspeptin treatment led to the activation of both PKR and PP2A.
  • PKR activation was upstream of PP2A phosphorylation, as indicated by inhibitor studies.
  • Cell proliferation was not affected by kisspeptin treatment.

Conclusions:

  • Kisspeptin inhibits colorectal cancer cell invasiveness through the KISS1R-PKR-PP2A signaling pathway.
  • The PKR-PP2A axis plays a critical role in mediating kisspeptin's anti-metastatic effects in colorectal cancer.
  • Targeting this pathway may offer a novel therapeutic strategy for preventing colorectal cancer metastasis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K